FibroBiologics, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
FibroBiologics, Inc. (FBLG) had Shares Issued, Shares, Share-based Payment Arrangement, Forfeited of 700.00 thousand shares as of 2024-10-18, per its 10-K filed 2026-02-24.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited · last filed 2026-02-24
- 2024-10-18: Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 700.00K shares.
- 2024-08-26: Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 500.00K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited |
|---|---|
| 2024-10-18 | 700.00K shares 10-K · filed 2026-02-24 |
| 2024-08-26 | 500.00K shares 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |